A novel microporous biomaterial vaccine platform for long-lasting antibody mediated immunity against viral infection
Description
Current antigen delivery platforms, such as alum and nanoparticles, are not readily tunable, thus may not generate optimal adaptive immune responses. We created an antigen delivery platform by loading lyophilized Microporous Annealed Particle (MAP)
